Aspire Biopharma Holdings, Inc. (ASBP) financial statements and ratios from SEC XBRL: revenue $6202.00 (TTM), net margin -394725.1%, revenue growth -98.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $6202.00 |
| Net Margin | -394725.1% |
| Revenue Growth (YoY) | -98.9% |
| Price / Book | 0.95 |
| Price / Sales | 92.04 |
| Altman Z-Score | -80.36 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ASBP overview · ASBP earnings · ASBP KPIs · ASBP investor relations · ASBP ownership · ASBP peers · ASBP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.